Avalyn Pharma
AVLNBiotech & Healthcare · NASDAQ · IPO April 30, 2026
01
Company Overview
Avalyn Pharma is filing to list on NASDAQ Global Select. Public information at this stage is limited to the IPO calendar entry; deeper detail typically becomes available closer to pricing via the company's S-1 / prospectus.
Avalyn Pharma is going public on NASDAQ Global Select on 2026-04-30. Offering 16,666,667 shares.
Recent headlines
- Avalyn Announces Pricing of Upsized Initial Public Offering - Nasdaqnasdaq.com
The shares are expected to begin trading on the Nasdaq Global Select Market on April 30, 2026 under the ticker symbol “AVLN.” The offering is ...
- Avalyn brings in $300M from oversized IPO - Fierce Biotechfiercebiotech.com
Avalyn heads to Nasdaq with oversized $300M IPO to fund reformulated respiratory drugs. By James Waldron Apr 30, 2026 3:18am. Avalyn ...
- Avalyn Pharma Rings the Opening Bell - Nasdaqnasdaq.com
The company is advancing optimized inhaled formulations of established antifibrotic medicines with the aim of transforming the treatment ...
- Avalyn Announces Closing of Initial Public Offering and Full ...firstwordpharma.com
Avalyn's common stock is listed on the Nasdaq Global Select Market under the ticker symbol “AVLN.” Morgan Stanley, Jefferies, Evercore ISI and ...
- Avalyn, in pursuit of better lung drugs, banks $300M in an IPObiopharmadive.com
Avalyn will begin trading Thursday on the Nasdaq stock exchange under the ticker symbol “AVLN.” Avalyn's offering is the eighth for a young ...
02
AI Analysis
Possible growth narrative
Sits adjacent to Biotech & Healthcare — themes that are currently drawing meaningful capital and attention.
Risks
Newly public companies typically face limited operating history disclosure, lock-up expirations, and broader market sentiment swings around IPOs.
Volatility
Expect elevated price volatility in the first weeks of trading as supply and demand find balance.
Market attention
Recently listed — monitoring early trading activity and analyst initiations.
Educational summary only. Not investment advice.
03
Related Themes
04
IPO Information
- IPO date
- April 30, 2026
- Exchange
- NASDAQ
- Status
- Recently Listed
- Industry
- Biotech & Healthcare
- Valuation
- $300.0M raise
- Headquarters
- —
- Attention score
- 61 / 100
- Ticker
- AVLN